Study on the Antirejection Effects of the Dual ICOS and CD28 Antagonist Acazicolcept (ALPN-101) in Mouse Skin and Heart Transplantation Models.

acazicolcept (ALPN-101) - AbbVie

Nulojix (belatacept) - BMS

prezalumab (AMG 557) - Amgen, AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42717303

Jianxi Wang; Leigang Guo; Lin Li; Panpan Zhan; Tingting Ma; Xiaojingnan Ma; Yaojuan Liu; Zhen Yang; Zhongyang Shen

Sep 11, 2026